Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes |
| |
| Authors: | Huynh K Kiriazis H Du X-J Love J E Jandeleit-Dahm K A Forbes J M McMullen J R Ritchie R H |
| |
| Institution: | (1) Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria, 8008, Australia;(2) Department of Medicine, Monash University, Clayton, VIC, Australia;(3) Department of Physiology, Monash University, Clayton, VIC, Australia; |
| |
| Abstract: | Aims/hypothesis An increase in the production of reactive oxygen species is commonly thought to contribute to the development of diabetic
cardiomyopathy. This study aimed to assess whether administration of the antioxidant coenzyme Q10 would protect the diabetic heart against dysfunction and remodelling, using the db/db mouse model of type 2 diabetes. Furthermore, we aimed to compare the efficacy of coenzyme Q10 to that of the ACE inhibitor ramipril. |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
